Press release
Cell Regeneration Medicine Market Poised for 14.4 % Growth, Set to Hit $82.68 Billion by 2029
Cell Regeneration Medicine Market
The increasing trend of organ transplantation is predicted to accelerate the progress of the cell regeneration medicine market. Organ transplantation is a surgical process wherein an organ from one individual is transferred to another recipient's body to replace a malfunctioning or absent organ. Its rising popularity can be attributed to its potential for extending life expectancy and bypassing medical treatments like dialysis. By concentrating on repairing and rebuilding damaged tissues or organs, cell regenerative medicine can potentially revolutionize organ transplantation. For instance, the United Network for Organ Sharing, a US-based scientific and educational body, reported approximately 42,887 organ transplants carried out in the United States in 2022, indicating a growth of 3.7% in comparison to 2021. Hence, the growing acceptance of organ transplants is anticipated to boost the cell regeneration medicine market. The anticipated surge in the cell regeneration medicine market can be linked to the increasing instances of chronic conditions. Referring to a persistent type of illness that lingers for three months or more and may progressively worsen over time, chronic diseases present a range of possibilities for cell regeneration medicine. It provides innovative ways to rejuvenate and mend damaged tissues and organs, opening up new pathways for research and treatments that might drastically alter the chronic disease management and treatment strategies. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, noted that the age-standardized death rate due to chronic diseases was 448 per 100,000 population, slightly increased to 459 per 100,000 in 2021, and then escalated further to 490 per 100,000 in 2022. Consequently, the increasing instances of chronic diseases are propelling the growth of the cell regeneration medicine market.
Get Your Cell Regeneration Medicine Market Report Here:
https://www.thebusinessresearchcompany.com/report/cell-regeneration-medicine-global-market-report
What Is the projected market size and growth rate for the cell regeneration medicine market?
In recent times, the market for cell regeneration medicine has seen a fast-paced growth. The market size is anticipated to expand from $41.83 billion in 2024 to reach $48.25 billion in 2025, representing a compound annual growth rate (CAGR) of 15.4%. The outstanding growth seen in the historical period is the result of an aging population, the rise in chronic diseases, an increase in government and corporate funding, and rising demand for functional regenerative medicine products.
In the forthcoming years, the market size for cell regeneration medicine is anticipated to experience swift expansion. By 2029, it is forecasted to inflate to $82.68 billion, growing at a compound annual growth rate (CAGR) of 14.4%. The factors contributing to this growth during the forecast period include a rise in the horeca sector's demand for regenerative medicine products, a scarcity of organs available for transplant, an increase in research and development activities, and a growing demand for gene therapies. Critical trends predicted during this period include advancements in therapeutic methods, expansion of clinical trials, progress in tissue engineering and 3D bioprinting, the rise of exosome-based therapies, and personalized medicine.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12884&type=smp
What are the emerging trends shaping the future of the cell regeneration medicine market?
Key players in the cell regeneration medicine market are prioritizing the creation of medical-grade bioink to maintain their competitive positioning. Essentially, medical-grade bioink is a specially crafted ink used in bioprinting that meets rigorous regulatory standards for safety and biocompatibility, rendering it ideal for roles in tissue engineering, regenerative medicine, and the production of biological structures for medical purposes. For example, in October 2023, CELLINK, a corporation based in Sweden with expertise in cell regeneration medicine products and technology, introduced CELLINK Vivoink. This is the initial medical-grade bioink specifically designed for clinical usage in tissue engineering and regenerative medicine, offering enhanced printability, mechanical stability, and cell viability.
What major market segments define the scope and growth of the cell regeneration medicine market?
The cell regeneration medicine market covered in this report is segmented -
1) By Product: Therapeutics, Tools, Banks, Services
2) By Therapeutic Category: Dermatology, Musculoskeletal, Immunology And Inflammation, Oncology, Cardiovascular, Ophthalmology, Other Therapeutic Categories
3) By End-User: Hospitals And Clinics, Commercial Industries, Government And Academic Research Institutes
Subsegments:
1) By Therapeutics: Stem Cell Therapies, Gene Therapies, Tissue Engineering Products
2) By Tools: Cell Culture Equipment, Bioreactors, Imaging Systems
3) By Banks: Stem Cell Banks, Tissue Banks, Cord Blood Banks
4) By Services: Cell Processing Services, Research And Development Services, Clinical Trial Services
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12884
Which region dominates the cell regeneration medicine market?
North America was the largest region in the cell regeneration medicine market in 2024. The regions covered in cell regeneration medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which key market leaders are driving the cell regeneration medicine industry growth?
Major companies operating in the cell regeneration medicine market are Pfizer Inc., Johnson & Johnson, F.Hoffman-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., ViaCord LLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Cook Biotech Inc., Integra LifeSciences Holdings Corporation, NuVasive Inc., Organogenesis Holdings Inc., AMAG Pharmaceuticals Inc., Takara Bio Inc., MiMedx Group Inc., Vericel Corporation, Mesoblast Limited, Osiris Therapeutics Inc., Guanhao Biotech Co. Ltd., CordLife Group Limited, FUJIFILM Cellular Dynamics Inc., Cesca Therapeutics Inc., U.S. Stem Cell Inc., Cytori Therapeutics Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12884&type=smp
What Is Covered In The Cell Regeneration Medicine Global Market Report?
• Market Size Forecast: Examine the cell regeneration medicine market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the cell regeneration medicine market for a structured understanding.
• Key Players Overview: Analyze major players in the cell regeneration medicine market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cell regeneration medicine market.
• Segment Contributions: Evaluate how different segments drive overall growth in the cell regeneration medicine market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cell regeneration medicine market.
• Industry Challenges: Identify potential risks and obstacles affecting the cell regeneration medicine market.
• Competitive Landscape: Review strategic developments in the cell regeneration medicine market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell Regeneration Medicine Market Poised for 14.4 % Growth, Set to Hit $82.68 Billion by 2029 here
News-ID: 3905884 • Views: …
More Releases from The Business Research Company
2025-2034 Mainframe Modernization Market Evolution: Emerging Opportunities and M …
What Is the Projected Size of the Mainframe Modernization Market by 2025?
Recent years have witnessed substantial expansion in the market dedicated to mainframe modernization, with projections indicating a climb from a valuation of $15.72 billion in 2024 up to $18.12 billion by 2025, a trajectory translating to a compound annual growth rate (CAGR) of 15.2%. This historical upward trend is fueled by several key factors, chief among them being escalating…
Accelerated Digital Transformation Fuels Expansion in the Liquid Crystal Polymer …
How Much Will the Liquid Crystal Polymer (LCP)-Based Molded Interconnect Device Market Size Increase by 2025?
The market for liquid crystal polymer (LCP)-based molded interconnect devices has experienced swift augmentation recently, projected to escalate from a value of $0.64 billion in 2024 to $0.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.3%. This historical expansion is largely traceable to several key factors, including the wider acceptance of…
Consistent Growth Projected for Land-Based Command, Control, Communications, Com …
How Much Is the Land-Based Command, Control, Communications, Computers, Intelligence, Surveillance, And Reconnaissance( C4ISR ) Market Expected to Expand by 2025?
The terrestrial C4ISR sector has experienced robust expansion lately, projected to increase its valuation from $32.64 billion in 2024 to $34.87 billion the following year, reflecting a steady compound annual growth rate of 6.8%. This upward trajectory in the past phase is traceable to several key factors, including a more…
Surging Application Across End Users Powers the Expansion of the Intelligent Ele …
How Large Is the Intelligent Electrical Panel Market Expected to Be by 2025?
The electrical panel segment characterized by intelligence has experienced swift expansion recently, projected to escalate its valuation from a total of $4.47 billion in the year 2024 to $4.95 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.7%; this upward trajectory throughout the preceding period is linked to several factors, namely the escalating need for…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
